Abbott’s TactiFlex Duo combines pulsed field ablation and radiofrequency energy in one contact-force catheter, giving electrophysiologists a way to move between tissue-selective PFA and conventional thermal ablation without changing platforms during an AFib procedure.
Radiofrequency burns and cryoballoon freezes cardiac tissue to isolate pulmonary veins. Pulsed field ablation instead uses microsecond electrical pulses to disrupt myocardial cells, offering a nonthermal route that may reduce collateral injury while delivering comparable rhythm control.
Johnson & Johnson has received U.S. Food and Drug Administration approval for the Dual Energy Thermocool Smarttouch SF Platform, an integrated cardiac ablation system that allows electrophysiologists to deliver both radiofrequency and pulsed field energy through a single catheter. The approval places the Johnson & Johnson MedTech electrophysiology business into a more direct U.S. rollout
The Dual Energy THERMOCOOL SMARTTOUCH SF Platform gives electrophysiologists pulsed field and radiofrequency ablation through one catheter, expanding procedural flexibility while raising new questions about evidence, efficiency and adoption.